Abstract
Neurocysticercosis is one of the most frequent parasitic diseases affecting the central nervous system. The introduction of anticysticidal therapy in the early 80s and the concomitant improvement of the radiological techniques have lead to apparently significant progress in patient prognosis. However, due to the specificity of the disease, a great debate has been generated on the real usefulness of cysticidal drugs. This article revises and discusses the pharmacological aspects of cysticidal treatment and summarizes current indications for the different types of the disease.
Keywords: Neurocysticercosis, taenia solium, treatment, albendazole, praziquantel, corticosteroids
Current Topics in Medicinal Chemistry
Title: Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives
Volume: 8 Issue: 5
Author(s): Agnes Fleury, Helgi Jung, Graciela Cardenas and Edda Sciutto
Affiliation:
Keywords: Neurocysticercosis, taenia solium, treatment, albendazole, praziquantel, corticosteroids
Abstract: Neurocysticercosis is one of the most frequent parasitic diseases affecting the central nervous system. The introduction of anticysticidal therapy in the early 80s and the concomitant improvement of the radiological techniques have lead to apparently significant progress in patient prognosis. However, due to the specificity of the disease, a great debate has been generated on the real usefulness of cysticidal drugs. This article revises and discusses the pharmacological aspects of cysticidal treatment and summarizes current indications for the different types of the disease.
Export Options
About this article
Cite this article as:
Fleury Agnes, Jung Helgi, Cardenas Graciela and Sciutto Edda, Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives, Current Topics in Medicinal Chemistry 2008; 8 (5) . https://dx.doi.org/10.2174/156802608783790811
DOI https://dx.doi.org/10.2174/156802608783790811 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Depression as a Comorbidity in Behcet's Syndrome
CNS & Neurological Disorders - Drug Targets FDG-PET/CT for Systemic Infections
Current Molecular Imaging (Discontinued) Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Dimethyloxallyl Glycine-Incorporated Borosilicate Bioactive Glass Scaffolds for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects
Current Drug Delivery Cardiovascular Disease in the Systemic Vasculitides
Current Vascular Pharmacology ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Macrophages in Inflammation
Current Drug Targets - Inflammation & Allergy Cytotoxic T Lymphocyte Antigen 4 Gene +49 A/G (rs231775) Polymorphism and Susceptibility to Systemic Lupus Erythematosus
Current Rheumatology Reviews Carotid Artery Disease: Current Concepts on Endothelial Dysfunction and Matrix Remodeling
Current Drug Therapy Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Current Pharmaceutical Biotechnology PPARγ and Early Human Placental Development
Current Medicinal Chemistry Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism A Review of the Treatment of Psoriasis with Infliximab
Reviews on Recent Clinical Trials Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Giant Cell Arteritis - Beyond the Headache
Current Rheumatology Reviews Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets